Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Genetic polymorphism of the CYP2C9 subfamily of 3 different races in warfarin maintenance dose.

Literature DB >> 15540908

Genetic polymorphism of the CYP2C9 subfamily of 3 different races in warfarin maintenance dose.

Gin Gin Gan, Maude Elvira Phipps, Chee Seng Ku, Alan Teh, Vijaya Sangkar.

Abstract

Entities: Chemical Gene

Mesh：

Substances：

Year: 2004 PMID： 15540908 DOI： 10.1532/ijh97.a20401

Source DB: PubMed Journal: Int J Hematol ISSN： 0925-5710 Impact factor: 2.490

× No keyword cloud information.

9 in total

1. The role of the CYP2C9-Leu359 allelic variant in the tolbutamide polymorphism.

Authors: T H Sullivan-Klose; B I Ghanayem; D A Bell; Z Y Zhang; L S Kaminsky; G M Shenfield; J O Miners; D J Birkett; J A Goldstein
Journal: Pharmacogenetics Date: 1996-08

2. Population differences in S-warfarin metabolism between CYP2C9 genotype-matched Caucasian and Japanese patients.

Authors: Harumi Takahashi; Grant R Wilkinson; Yoseph Caraco; Mordechai Muszkat; Richard B Kim; Toshitaka Kashima; Sosuke Kimura; Hirotoshi Echizen
Journal: Clin Pharmacol Ther Date: 2003-03 Impact factor: 6.875

3. Racial background is a determinant of average warfarin dose required to maintain the INR between 2.0 and 3.0.

Authors: A Blann; J Hewitt; F Siddiqui; D Bareford
Journal: Br J Haematol Date: 1999-10 Impact factor: 6.998

4. Association of polymorphisms in the cytochrome P450 CYP2C9 with warfarin dose requirement and risk of bleeding complications.

Authors: G P Aithal; C P Day; P J Kesteven; A K Daly
Journal: Lancet Date: 1999-02-27 Impact factor: 79.321

5. Genetic polymorphism in exon 4 of cytochrome P450 CYP2C9 may be associated with warfarin sensitivity in Chinese patients.

Authors: A Y Leung; H C Chow; Y L Kwong; A K Lie; A T Fung; W H Chow; A S Yip; R Liang
Journal: Blood Date: 2001-10-15 Impact factor: 22.113

6. Genetic analysis of the human cytochrome P450 CYP2C9 locus.

Authors: M J Stubbins; L W Harries; G Smith; M H Tarbit; C R Wolf
Journal: Pharmacogenetics Date: 1996-10

7. Racial background is a determinant factor in the maintenance dosage of warfarin.

Authors: Gin Gin Gan; Alan Teh; Kim Yen Goh; Heng Thay Chong; Kang Wah Pang
Journal: Int J Hematol Date: 2003-07 Impact factor: 2.490

8. Detection of CYP2C9 polymorphism based on the polymerase chain reaction in Chinese.

Authors: S L Wang; J Huang; M D Lai; J J Tsai
Journal: Pharmacogenetics Date: 1995-02

Review 9. Pharmacogenetics of warfarin elimination and its clinical implications.

Authors: H Takahashi; H Echizen
Journal: Clin Pharmacokinet Date: 2001 Impact factor: 5.577

9 in total

5 in total

1. Call to action: cardiovascular disease in Asian Americans: a science advisory from the American Heart Association.

Authors: Latha P Palaniappan; Maria Rosario G Araneta; Themistocles L Assimes; Elizabeth L Barrett-Connor; Mercedes R Carnethon; Michael H Criqui; Gordon L Fung; K M Venkat Narayan; Hamang Patel; Ruth E Taylor-Piliae; Peter W F Wilson; Nathan D Wong
Journal: Circulation Date: 2010-08-23 Impact factor: 29.690